- Written by Staff
Dr Ananthanababu Pattavilakom Sadasivan ("Dr Babu") is an experienced Australasian Fellowship qualified neurosurgeon. After his initial medical training in India he spent ten years working in neurosurgical centres around Australia including Monash in Melbourne and Nepean Hospital in Sydney, as well as teaching at Sydney University. More recently he has completed a spine surgery fellowship at Princess Alexandra Hospital in Brisbane. Dr Babu also holds a pain management fellowship, FFPMANZCA, from the Faculty of Pain Medicine, Australian and New Zealand College of Anaesthetists.
- Written by Harald Puhalla, MD FRACS, Assoc Prof of Surgery, Griffith University
In Australia more than one million people are diagnosed with type 2 diabetes and at least two million have pre diabetes.
The rapid increase of type 2 diabetes goes in hand with the well-known obesity epidemic. A strong association in-between increased body fat and insulin resistance was initially described as part of the Syndrome X in the 1980’s. More recently in conjunction with hypertension and hyperlipidaemia, obesity and elevated glucose level were named metabolic syndrome. 80% of patients with type 2 diabetes are obese or overweight. When their diabetes becomes clinically apparent the risk for cardiovascular events rises sharply. In these patients obesity additionally increases their possibility of developing pulmonary embolism, cancer, osteoarthritis, depression or asthma.
- Written by Dr Michelle Crockett
Dr Michelle Crockett is the Clinical Lead and Senior HealthPathways GP Clinical Editor for the WentWest Primary Health Network's HealthPathways project.
HealthPathways began in New Zealand and is an online tool designed to help GPs assess and manage conditions. In addition there is information about local referral options. It is now used in Australia with about 13 sites working on their own pathways. At Western Sydney we began our journey in 2012 starting with the diabetes pathways. Our first batch of pathways went live in November 2013 and we now have over 100 pathways on our live site and 100 more almost ready for publication.
- Written by David Guest
The pathway is designed to give GPs a quick guide to the management of hepatitis C patients on the North Coast. A brief overview and flowchart are sufficient to determine if patients would qualify and benefit from referral. To save time the pathway has a list of recommended pre-assessment blood tests.
- Written by Robin Osborne
A detailed study of 3,906 GPs – nearly one-in-five of the national GP workforce – has revealed that small-sized towns face the highest risk of GP turnover, with key influencing factors being GPs working in a location for less than three years, being contracted or salaried employees, or international medical graduates.
While remote and very remote GPs had the highest mobility rate, this group was not at significantly greater risk of leaving non-metropolitan practice completely. Rural GPs practising in towns of less than 5,000 residents, and in towns of up to 15,000 residents, were most likely to move to metropolitan areas.
Overall, annual location retention rates were 95 per cent in regional centres, 90 per cent in small rural towns, and 82 per cent in very remote areas.
Page 83 of 104